Search results
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Pages for logged out editors learn more
Glenmark Pharmaceuticals was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. He named the company after his two sons. The company initially sold its products in India, Russia, and Africa.
Jul 26, 2012 · Gracias Saldanha, who started Glenmark Pharmaceuticals in 1977, recently passed away in Mumbai. A veteran of the pharmaceutical industry, he remained a guiding force to the management for the next three decades, retiring as Chairman and Non-Executive Director in 2011.
Board of Director : Glenn Saldanha · Chairman & Managing DirectorGlenn Saldanha · Cherylann Pinto · Executive Director – Corporate...
The story begins in 1977. Saldanha starts a pharmaceutical company named after his two sons - Glenn and Mark. This is the beginning of a global pharmaceutical company - Glenmark Pharmaceuticals.
Jun 24, 2020 · Glenmark Pharmaceuticals was founded by Gracias Saldanha in 1977 in India, as a generic drug and active pharmaceutical ingredient (API) manufacturer. Initially, they were into the manufacturing of oral tablets, liquids, and capsules. With time, many other products were added to the portfolio.
Nov 13, 2008 · Net Worth: $825 million/Mumbai Age: 70. Married, 4 children Former drug company executive started Glenmark Pharmaceuticals in 1977. Firm sells generic drugs in 95 countries. Its research labs churned out new drug candidates for osteoarthritis, diabetes and multiple sclerosis, now licensed to big pharma firms for development. Stock fell recently when Eli Lilly suspended trials of a pain molecule it was jointly developing with Glenmark. Gracias Saldanha
Late Mr. Gracias Saldanha (1938- 2012) A dream, a belief and one million rupees. Only a visionary like Mr. Gracias Saldanha could build one of India’s leading pharmaceutical companies with nothing more than
Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the United States Food and Drug Administration (FDA) for Ryaltris™ Nasal Spray for the Treatment of Symptoms of Seasonal Allergic Rhinitis in Adults and Pediatric Patients 12 Years of Age and Older
Biography. Mr. Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Ltd. He joined in 1998 as Director and took over as Managing Director & CEO in 2001.
